Percival Barretto-Ko
Independent DirectorMr. Percival Barretto-Ko, MBA, serves as Independent Director at Spruce Biosciences Inc since May 2023. He served as Director at Alessa Therapeutics, Inc. He served as President, Chief Executive Officer & Director of Plexium, Inc until June 2024. Mr. Barretto-Ko has been President of Astellas US LLC since March 15, 2018. Mr. Barretto-Ko was President of Astellas Pharma US, Inc. He served as Chief Business Officer at Astellas Pharma Inc. from 2021 to September 2021. He served as the President of US Commercial at Astellas Pharma Inc. from 2019 to 2021. He served as the President of Americas Operations at Astellas Pharma Inc. until 2019. He was Senior Vice President of International Operations at Astellas Pharma Inc. He served as Senior Vice President of International Operations at Astellas Pharma US, Inc. since February 2015. He served as Senior Vice President of Corporate Strategy & Government Affairs at Astellas US Holding, Inc. since August 19, 2011. He served as Senior Vice President of Corporate Strategy and Government Affairs at Astellas US, LLC. He has been a Director of Audentes Therapeutics, Inc. since January 15, 2020. He served as Senior Vice President of Corporate Strategy & Government Affairs at Astellas Pharma, Inc. He served as an Executive Director of Corporate Strategy & Communications at Astellas Pharma Europe Ltd. He led the global launch of Astellas' new pipeline drug, Advagraf (tacrolimus prolonged release) in 20 countries. He also lead the organization's corporate planning function and ultimately directed corporate strategy, corporate planning, corporate communications, crisis management and corporate social responsibility. Prior to Astellas, he held increasingly more senior marketing and sales positions with the Roche Group in the US and UK. He has been a Director of Illinois Biotechnology Industry Organization since January 20, 2014. Mr. Percival earned a Bachelor of Science in biological sciences from Cornell University, a Master of Business Administration from Yale School of Management and a Master of Science from MIT Sloan School of Management, where he served as a Sloan Fellow for Innovation and Global Leadership.
Positions
- Company NameSpruce Biosciences, Inc.Stock CodeSPRBPositionIndependent DirectorColleagues
